Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07534397 · ClinicalTrials.gov registry record · NA
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
A NA study, sponsored by The University of Texas at Dallas.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07534397 is a NA study that has not yet begun recruiting, run by The University of Texas at Dallas. The registered enrollment target is 20 participants.
The verdict
NCT07534397, a NA study, has not yet begun recruiting, sponsored by The University of Texas at Dallas.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to examine the effects of transcranial Direct Current Stimulation (tDCS) on verbal retrieval and cognition and sensorimotor control and to determine if tDCS can be used as a way to improve retrieval, sensory, and motor abilities in individuals with Parkinson's disease (PD).
Interventions
- DEVICE Sham transcranial direct current stimulation
- DEVICE transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07534397
The ClinicalTrials.gov registry entry for NCT07534397 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham transcranial direct current stimulation is the first listed.
NCT07534397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07534397 about?
NCT07534397 is a clinical study titled "Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation". The purpose of this research study is to examine the effects of transcranial Direct Current Stimulation (tDCS) on verbal retrieval and cognition and sensorimotor control and to determine if tDCS can be used as a way to improve retrieval, sensory, and motor abilities in individuals with Parkinson's d...
What is the current status of trial NCT07534397?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08-01. Estimated completion is 2027-10-31.
What interventions are being tested in trial NCT07534397?
The interventions under investigation include: Sham transcranial direct current stimulation (DEVICE), transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT07534397?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.